FDA Rejects New Diabetes Drug That Contains Actos
A new diabetes drug from Takeda Pharmaceuticals will not reach the market, thanks to a recent FDA ruling. The FDA ordered Takeda, manufacturer of the controversial diabetes drug Actos, to provide data showing that the new drug was received positively in foreign markets where it was already approved. Thousands of patients who took Actos have filed an Actos lawsuit against Takeda. The drug may cause Actos bladder cancer, say Actos lawyer representatives on behalf of their clients. Actos was pulled from some foreign markets by concerned regulators.
Drug Side Effects is dedicated to bringing the latest news and information on personal injury lawsuits involving dangerous drugs, defective products and other lawsuits impacting the safety and well being of consumers in the US. We believe that people should be informed about dangerous products, serious side effects and breaking news on what's happening behind the scenes as lawsuits are initiated and adjudicated through the court system.
If there are topics that you would like to know more about, feel free to send us an email and we'll do our best to help add those subjects to our news schedule.